Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • spacup
    Member
    • Apr 2013
    • 17

    #1

    A question about EdgeR

    Hi all,

    I am trying to understand EdgeR...
    I made a table of counts and used it in EdgeR.
    I used the exact Test to compare condition 2 (3 replicates) with condition 3 (2 replicates):

    et<-exactTest(y,pair=c("2","3"))

    I then export the result :

    write.table(et$table, "EgdeR_TMM.csv", sep="\t")

    and I have a file with 2689 genes.

    Are all that genes DE?
    If yes, why some p-value are around 1 ?
    Should I filter these genes by p-value? And which is the correct limit? 0.05? 0.5?

    I found some comments from Simon Anders who says :
    "You should not put thresholds on raw p values, but use an adjustment for multiple testing. edgeR (and DESeq) use the Benjamini-Hochberg (BH) procedure by default. If you want to cut BH-adjusted p values at 1%, you are unusually stringent. A commonly chosen threshold is 10%, but whether this is appropriate depends, of course, on what you want to do afterwards with the result."
    and
    "And just as a reminder: Don't even think about thresholding the raw p values in genomic experiments. This is nearly always nonsense[...]"
    and
    "The Benjamini-Hochberg adjustment, which formalizes this argument, will hence adjust a raw p value of 0.05 to an adjusted p value of 0.5."
    Thus, I am a little bit lost....
    If someone could enlighten me, I would be very grateful !
    Thanks.

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
24 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
20 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
36 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
42 views
0 reactions
Last Post SEQadmin2  
Working...